| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |